Thyrotropin suppression therapy for papillary thyroid carcinoma with a huge recurred neck lymph node

Abstract

Differentiated thyroid cancer (DTC) originating from thyroid tissue is affected by thyrotropin (TSH). TSH suppression therapy is usually recommended after thyroidectomy in cases of DTC. A 57-year-old woman who harbored a very huge recurred lymph node underwent TSH suppression therapy because of the risk of surgical complications. After TSH suppression, the huge neck lymph node exhibited a response and decreased in size. She had been followed up for 144 months. TSH suppression therapy could be considered as an alternative treatment option in a recurred DTC patient with a high perioperative risk.

Keywords

• papillary thyroid carcinoma
• thyrotropin
• active surveillance
• locoregional neoplasm recurrence
• case report